This book, a second edition, includes new data from the 2010 Census of India and NSS reports on consumer expenditure (2011-12), health and education (2014) to examine poverty in China and India, and how it connects with minorities. Poverty has generally become less acute in both China and India, thanks to an impressively rapid growth especially between 2010 and 2015 when the rest of the world including the US and the EU slowed down following the economic recession of 2008. But the issues of income and non-income inequalities (especially malnutrition in India), marginalization and social exclusion remain as acute as ever in both countries. As well as the use of new primary material in every chapter, the book also critically examines new relevant studies and responds to global perspectives on minority issues. It canvasses a broad range of subjects from global terrorism and civil wars in Libya and Syria, to the Arab Spring and the emergence of Islamic fundamentalism and the Islamic State (ISIS).

The Chinese insurance industry has experienced rapid development during the past decade. This original book is the first English language study in the literature to address the efficiency issue of the Chinese insurance sector, and presents a comprehensive review on alternative methodologies for analyzing firm efficiency.The authors suggest alternative ways to improve performance of insurance companies in China and make useful policy recommendations on regulation, competition and development of the insurance industry. They expand the applications of data envelopment analysis and stochastic frontier analysis in the literature on technical efficiency and discuss managerial implications for both insurance companies and policymakers. Performance of the Chinese Insurance Industry under Economic Reforms will be significant for academic researchers and students of economics, finance and business. Managers of financial institutions in China and the rest of the world will find this important book intriguing, as will policymakers and regulators working in the financial and insurance industries.

DNA delivery into cells is a rapidly developing area in gene therapy and biotechnology. Moreover, it is a powerful research tool to determine gene structure, regulation, and function.

Viral methods of DNA delivery are well-characterized and efficient, but little is known about the toxicity and immunogenecity of viral vectors. As a result, non-viral, transfection methods of DNA delivery are of increasing interest.

Synthetic DNA Delivery Systems is a comprehensive and current resource on DNA transfection. The use of histidine-rich peptides and polypeptides as DNA delivery systems and self-assembled delivery systems based on cationic lipids and polymers are discussed. Targeted delivery to organelles, tumor cells and dendritic cells comprise an important topic.